MedTech aims to diagnose diabetes from fingernails

MedTech firm Glyconics has secured £1.5 million in an enterprise investment scheme funding round ahead of a Series A round next year. The innovative diagnostics startup, with offices in Cambridge, Norwich and Basingstoke, raised well over the intended £850k in a raise led by investment platform Wealth Club plus existing investors Deepbridge Capital and Boundary … Continue reading MedTech aims to diagnose diabetes from fingernails